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OBJECTIVES: The FRAX® model recently developed by the WHO calculates 10-year 
probability of major osteoporotic and hip fracture, offering new basis for medical 
decision making and health economic analysis in osteoporosis (OP). [http://www.shef.
ac.uk/FRAX/]. Patients’ ideas regarding fracture risk and longevity might inﬂ uence 
their perception of 10-year fracture risk data and compliance, and as a consequence, 
successful implementation of FRAX® based thresholds in everyday OP care. Our aim 
was to study whether FRAX® data differ from OP patients’ and attendant especialists’ 
self-estimations on fracture risk. We also assessed expectations on longliving which is 
a crucial point to perceive the 10-year farcture risk projection of FRAX® relevant. 
METHODS: In 2009 a cross-sectional survey was performed in 10 Hungarian rheu-
matology centres. Postmenopausal OP patients appearing on routine visit and switch-
ing to second line antiporotic drug were involved. Demographics, main clinical 
characteristics were registered. Patients’ estimation on 10-year fracture risk and 
longliving were surveyed. Physicians’ expectations on patients’ perspectives were likely 
detected. FRAX® was calculated and matched with the estimations. RESULTS: 224 
patients were involved, mean(SD): age 69.5(8.9)years, duration of OP care 6.7(5.1)
years, lumbar Tsc-3.17(0.82), femoral Tsc-2.69(0.87), 133(59.4%) patients had OP 
fracture previously. Health status VAS was 59(17)mm. FRAX®-major OP fracture 
was 26(15.7)%, patients estimated 32.7(25.8)%, physicians marked 29.9(21.4)%. 
Results for hip fracture were: FRAX® 12.6(15.3)%, patients 26.7(25.3)%, physicians 
21.5(19.1)% (P < 0.01). Patients’ expected to live until age 82.4(8.2)years, physicians’ 
estimation was nearly same (82.5, SD7 yrs). Less than 10-year survival was expected 
by 42,4% and 33.7%, respectively. CONCLUSIONS: Both patients and physicians 
overestimate fracture risk, especially for hip. Patients often expect to live shorter than 
the time-frame of the fracture risk projection. These aspects should be highly consid-
ered in health communication and also in the application of the FRAX® method in 
clinical practice.
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OBJECTIVES: Rheumatoid Arthritis (RA), a chronic inﬂ ammatory disease, may pre-
dispose to the development of Type 2 Diabetes Mellitus (T2DM). We aimed to 
compare incidence rates of T2DM in RA versus non-RA populations and study the 
inﬂ uencing factors. METHODS: The study population consisted of participants in the 
National Data Bank for Rheumatic Diseases (NDB), where patients with rheumato-
logic disorders completed semiannual questionnaires, from 1998 through 2008. 
Osteoarthritis (OA) patients were used as controls. T2DM was determined based on 
self-reports of disease and on the use of hypoglycemic medication. The association 
between RA and T2DM was investigated using COX logistic regressions adjusted for 
relevant clinical and demographic covariates. RESULTS: A total of 14,481 partici-
pants diagnosed with RA (79.5% female; mean age 58.1 years) and 3,441 participants 
diagnosed with OA (84.5% female; mean age 63.6 years) were followed during 69,943 
person-years. RA subjects had lower Body Mass Index (BMI) and less major comor-
bidities than controls. In patients with RA the T2DM incidence rate was 10 per 1000 
person-years, while the incidence rate for OA was 15 per 1000 person-years. Both 
rates are superior to most estimates calculated among the US population. However, 
the covariate-adjusted risk of T2DM in patients with RA versus OA was not signiﬁ cant 
(HR = 0.94; 95% CI: 0.79–1.12, p = NS). Male gender, age, BMI, non-caucasian 
ethnicity, major comorbidities, low education level and prednisone intake were sig-
niﬁ cantly associated with the incidence of T2DM. Some RA drugs had a clear protec-
tive role on TDM2, mainly methotrexate (19% risk reduction; p = 0.022) and 
hydroxicloroquine (47% risk reduction; P < 0.001). CONCLUSIONS: RA per se is 
not associated with increased risk of T2DM. Both RA and OA are associated with 
known TDM2 risk factors, such as BMI and some comorbidities, increasing the 
incidence rates of TDM2. Some drugs for RA treatment have a signiﬁ cant protective 
effect on the TDM2 risk.
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OBJECTIVES: Total knee replacement (TKR) is a commonly used surgical procedure 
for patients with severe joint damage caused by arthritis; however, there remain dif-
ﬁ culties in establishing criteria to deﬁ ne the optimal timing for TKR. The aim of this 
study was to identify the preoperative threshold HRQoL scores that were associated 
with better postoperative outcomes and those associated with greater improvement. 
METHODS: Data were collected from 1715 patients undergoing TKR between 2001 
and 2006. Patients were interviewed at baseline and at 6 months and 2 years after 
surgery. At all three interview sessions, patients were asked to complete the Short-
Form (SF-36) and the Oxford Knee Score (OKS). As physical function and pain have 
been identiﬁ ed as the key domains in osteoarthritis, the OKS and the physical function-
ing (PF) and bodily pain (BP) scales of the SF-36 were selected as the outcome measures 
of this study. Summary statistics were computed for preoperative, postoperative, and 
improvement in outcome scores. Visual inspection of the simple error bar charts were 
used to identify the threshold preoperative scores that were associated with better 
postoperative scores and those associated with more improvement. RESULTS: 
Patients with poorer preoperative HRQoL had worse postoperative outcomes but 
experienced greater improvement after TKR compared to those with better preopera-
tive HRQoL. The highest postoperative PF scores are associated with a preoperative 
PF score of 50 points and above, whereas the baseline threshold OKS score was 
between 35 and 40 points. a baseline PF score of <30 points and an OKS score of 
>40 points are associated with the greatest improvement. No clear leveling off pattern 
was observed in the BP scores. CONCLUSIONS: PF and OKS threshold scores associ-
ated with optimal outcomes of TKR were identiﬁ ed in this study. Future research is 
needed to examine the predictive value of the scores identiﬁ ed in improving patients’ 
post-operative outcomes.
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OBJECTIVES: To examine health-related quality of life (HRQoL) following total knee 
replacement (TKR) or unicompartmental knee arthroplasty (UKA). METHODS: 
Asian adult patients undergoing either TKR or UKA in a hospital of Singapore 
between 2001 and 2006 were interviewed before surgery and 6 and 24 months post-
operatively to obtain demographic information and HRQoL scores using the Short-
Form (SF-36) and the Oxford Knee Score (OKS). RESULTS: Data were collected from 
2243, 1715, and 1113 patients at baseline, 6, and 24 months, respectively. TKR 
patients had a lower preoperative score than UKA patients on OKS and four subscales 
of the SF-36 (p < 0.01). Both TKR and UKA patients’ OKS and SF-36 subscale scores 
improved six months postoperatively except in the general health domain. SF-36 role 
physical (RP) and bodily pain (BP) scores showed the most improvement (40.9 and 
33.0 points in TKR and 36.9 and 31.4 points in UKA patients, respectively). The most 
substantial improvements between baseline and two years after surgery were in the 
physical domains of HRQoL (RP, BP, and physical functioning (PF)). In addition, in 
both groups, ﬁ ve domains of SF-36 (RP, BP, PF, social functioning, and role limitations 
due to emotional problems) reached the proposed minimal clinically important differ-
ence of ten points. TKR patients’ SF-36 and OKS scores were not signiﬁ cantly different 
from those of UKA patients two year after surgery, except PF scores. Multiple regres-
sion analysis adjusting for sociodemographics showed that baseline scores were a 
signiﬁ cant predictor of the postoperative scores of OKS and all SF-36 subscales (p < 
0.01), whereas the type of surgery was not associated with the postoperative scores. 
CONCLUSIONS: Both TKR and UKA patients experienced signiﬁ cant improvements 
in HRQoL, particularly in the RP and BP domains. After controlling for potential 
confounding variables, the type of surgery was not a signiﬁ cant predictor of patients’ 
postoperative HRQoL scores.
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OBJECTIVES: To describe back pain, and HRQoL in postmenopausal women with 
osteoporosis treated with teriparatide (Forsteo®) in France. METHODS: European, 
prospective, observational study of 36 months duration (18-month active treatment 
phase and 18-month post-treatment follow up) in postmenopausal women with osteo-
porosis who initiated teriparatide. HRQoL measured by EQ-5D and back pain mea-
sured by a Visual Analogue Scale (VAS) and a questionnaire were collected at each 
follow-up visit. RESULTS: Among 309 patients enrolled in France (18.8% of the total 
EFOS cohort), 290 (94.5%) had any follow-up data, and 201 (65.0%) completed the 
last post-treatment visit. At baseline, patients were 73.8 (7.4) years old (mean (SD)), 
